Article
Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa.
The Journal of infectious diseases - 15 Sept 2016
Boender T Sonia, Hamers Raph L, Ondoa Pascale, Wellington Maureen, Chimbetete Cleophas, Siwale Margaret, Labib Maksimos Eman E F, Balinda Sheila N, Kityo Cissy M, Adeyemo Titilope A, Akanmu Alani Sulaimon, Mandaliya Kishor, Botes Mariette E, Stevens Wendy, Rinke de Wit Tobias F, Sigaloff Kim C E
Abstract excerpt
BACKGROUND: As antiretroviral therapy (ART) programs in sub-Saharan Africa mature, increasing numbers of persons with human immunodeficiency virus (HIV) infection will experience treatment failure, and require second- or third-line ART. Data on second-line failure and development of protease inhibitor (PI) resistance in sub-Saharan Africa are scarce. METHODS: HIV-1-infected adults were included if they received...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.